A recent study published in Frontiers in Immunology examines the antibody response to natural infection or coronavirus disease 2019 (COVID-19) vaccination in individuals living with human...
In a recent study published in JAMA Network Open, researchers evaluate the risks of possible adverse events following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic...
Immunosuppressed individuals have lower responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and poorer coronavirus disease 2019 (COVID-19)-related consequences. Resistance to existing treatments, including...
In a recent study published in the Science Advances Journal, a group of researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV)...
In a recent study published in Nature Communications, a group of researchers investigated the neurotropic potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its...
The 2019 coronavirus disease (COVID-19) pandemic was caused by the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, COVID-19 has claimed the lives...
Recent Comments